Solventum Corp (SOLV): Revenue

Annual figures by period end, from SEC filings.

$8.32B

Year ended 2025-12-31

$8.31B

Trailing 12 months to 2026-06-30

+0.8%

3-year compound annual growth

2022-12-31 Revenue (USD) 2025-12-31

Period ended	Revenue	Change YoY	Source filing
2025-12-31	$8.32B	+0.9%	2026-02-27, From 2025-01-01
2024-12-31	$8.25B	+0.7%	2026-02-27, From 2024-01-01
2023-12-31	$8.20B	+0.8%	2026-02-27, From 2023-01-01
2022-12-31	$8.13B	n/a	2025-02-28, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Revenue	Change YoY
Solventum Corp (SOLV)	2025-12-31	$8.32B	+0.9%
Baxter International Inc (BAX)	2025-12-31	$11.24B	+5.7%
ResMed Inc (RMD)	2026-06-30	$5.65B	+9.9%
Dexcom Inc (DXCM)	2025-12-31	$4.66B	+15.6%
Boston Scientific Corp (BSX)	2025-12-31	$20.07B	+19.9%
Becton Dickinson & Co (BDX)	2025-09-30	$21.84B	+8.2%
MiniMed Group, Inc. (MMED)	2026-04-24	$3.10B	+14.3%
West Pharmaceutical Services Inc (WST)	2025-12-31	$3.07B	+6.3%
Globus Medical Inc (GMED)	2025-12-31	$2.94B	+16.7%

Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗